BioROSA Technologies Inc.
Founded 2017 · $740K raised
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Website
- biorosa.com
- Total Funding
- $740K
- Last Round
- $740K Convertible NoteNov 2022
- Rounds
- 2
About
BioROSA Technologies is developing biologically-based diagnostic tools for Autism Spectrum Disorder (ASD), aiming to make ASD diagnosis rapid and simple. The company's approach focuses on using biomarkers and metabolite panels (including FOCM/TS metabolites) to create a clinical standard of care for autism diagnosis. BioROSA has partnered with academic and clinical research institutions including the BRAIN Foundation and O'Sullivan Foundation, contributing to translational clinical studies published in peer-reviewed journals.
Summary
BioROSA Technologies Inc. is a Biotech company, founded in 2017. It has raised $740K in total across 2 rounds, most recently a $740K Convertible Note round in Nov 2022. Investors include SOSV and IndieBio.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...